📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Real-life experience of tocilizumab use in COVID-19 patients. (2020)

First Author: Madenidou AV

Attributed to: MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keaa325

PubMed Identifier: 32556278

Publication URI: http://europepmc.org/abstract/MED/32556278

Type: Journal Article/Review

Volume: 59

Parent Publication: Rheumatology (Oxford, England)

Issue: 8

ISSN: 1462-0324